Skip to content

#Access and funding

13 NovFri
  1. Psychedelic Alpha48

    HHS taps Mark Cuban's company to develop ibogaine for PTSD and commits $20M for real-world evidence network

    The U.S. Department of Health and Human Services said it will tap Mark Cuban's company to develop ibogaine for post-traumatic stress disorder and commit $20 million to a real-world evidence network. HHS Secretary RFK Jr. gave the update at a press conference, where VA Senior Advisor Andrew Gradison stood in for VA Secretary Doug Collins.

23 OctFri
  1. The Microdose (UC Berkeley BCSP)44

    ICER to review Compass Pathways' synthetic psilocybin COMP360 for treatment-resistant depression

    The Institute for Clinical and Economic Review announced on Wednesday it will evaluate the clinical effectiveness and cost of Compass Pathways' synthetic psilocybin COMP360 for treatment-resistant depression, with results to be discussed at the May 2027 meeting of the New England Comparative Effectiveness Public Advisory Council.

22 OctThu